SYSTEMATIC REVIEW
Published on 16 Sep 2022
Efficacy and safety of PD-1 and PD-L1 inhibitors combined with chemotherapy in randomized clinical trials among triple-negative breast cancer
doi 10.3389/fphar.2022.960323
- 3,212 views
- 9 citations
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Pharmacogenetics of Breast Cancer: How far we have come and what should we do?
Pharmacogenetics of Breast Cancer: How far we have come and what should we do?
6,254
Total downloads
18k
Total views and downloads
Articles
REVIEW
Published on 16 Sep 2022
Anticancer potential of cryptotanshinone on breast cancer treatment; A narrative review
doi 10.3389/fphar.2022.979634
- 2,064 views
- 15 citations
ORIGINAL RESEARCH
Published on 09 Sep 2022
Cost-effectiveness analysis of trastuzumab deruxtecan versus trastuzumab emtansine for HER2-positive breast cancer
doi 10.3389/fphar.2022.924126
- 7,684 views
- 19 citations
SYSTEMATIC REVIEW
Published on 30 May 2022
Efficacy and Safety of Initial 5 Years of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis
doi 10.3389/fphar.2022.886954
- 2,364 views
- 2 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore